|
You are here:
Education & Tools
>
|
|
 |
 Conference Highlights |
Antifungal Combinations
-
COMPARATIVE SAFETY OF AEROSOLIZED AMPHOTERICIN B LIPID COMPLEX (ABELCET) AND AMPHOTERICIN B DEOXYCHOLATE (FUNGIZONE) AS ANTIFUNGAL PROPHYLAXIS IN LUNG TRANSPLANT RECIPIENTS: A RANDOMIZED, DOUBLEBLIND STUDY
Drew RH, Davis RD, Palmer SM, Benjamin DK, Perfect JR, Duke University Medical Center,
Durham, United States
-
SUCCESSFUL TREATMENT OF CANDIDEMIA WITH CASPOFUNGIN AND LIPOSOMAL AMPHOTERICIN B AFTER FAILURE OF MONOTHERAPY
Nguyen HH, Avante CJ, Siddiqui J, King J, Cohen SH, University of California, Davis,
Sacramento, United States
-
NON-AZOLE ANTIFUNGALS AND CALCINEURIN INHIBITORS EXHIBIT SYNERGISTIC ACTIVITY AGAINST C. ALBICANS
Onyewu C, Blankenship JR, Duke University Medical Center, Durham, United States,
Del Poeta M, Medical University of South Carolina, Charleston, United States,
Heitman J, Duke University Medical Center, Durham, United States
-
THE COMBINATION OF LOW DOSE AMPHOTERICIN B AND MICAFUNGIN IS COMPARABLE IN ACTIVITY TO HIGH DOSE AMPHOTERICIN B ALONE IN TREATMENT OF EXPERIMENTAL INVASIVE PULMONARY ASPERGILLOSIS
Petraitis V, Petraitiene R, Sarafandi A, Kelaher A, Leguit RJ,
Irwin RG, Peter J, Bacher J, Walsh TJ, National Institute of
Health, National Cancer Institute , POB,
Bethesda, United States
|
|